Key Segmentation:
By Material Type
-
Metal-on-Polyethylene
-
Ceramic-on-Ceramic
-
Ceramic-on-Polyethylene
-
Metal-on-Metal
By Fixation Type
-
Cemented
-
Uncemented
-
Hybrid
By Application
-
Primary
-
Revision
By End-User
-
Hospitals
-
Ambulatory Surgical Centers
-
Orthopaedic Clinics
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Johnson & Johnson (DePuy Synthes), Smith & Nephew, Stryker Corporation, Zimmer Biomet Holdings, Corin Group, Exactech, Lima Corporate, MicroPort Orthopedics, Aesculap, and Medacta International, among others.
Continued advancement of robotic-assisted and AI-powered surgical guidance platforms and the continued development of antibacterial and iodine-treated implant coatings represent the two most significant opportunities shaping the market's next phase of growth.
Growth is primarily driven by rising osteoarthritis prevalence and an ageing population, combined with growing adoption of robotic-assisted surgical platforms improving implant placement precision.
By Application, Primary procedures dominated the market with an 81.70% share in 2025, reflecting their role as the foundational driver of overall hip reconstruction volume.
North America dominated the market with a 41.85% share in 2025, supported by a substantial ageing patient population and a dense concentration of leading implant manufacturers headquartered within the region.
